Werner Milton H. 13D and 13G filings for Inhibikase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-15 7:45 pm Purchase | 2022-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Werner Milton H. | 926,485 19.680% | 16,812 (+1.85%) | Filing |
| 2022-02-11 5:15 pm Purchase | 2021-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Werner Milton H. | 909,673 21.700% | 2,736 (+0.30%) | Filing |
| 2021-02-11 4:06 pm Purchase | 2020-12-22 | 13G | Inhibikase Therapeutics, Inc. IKT | Werner Milton H. | 906,937 53.100% | 906,937 (New Position) | Filing |